A special report, “Accelerating the Delivery of Patient-Centered, High-Quality Cancer Care,” proposes four key policy recommendations to further the national dialogue on accelerating the delivery of patient-centered, high-quality cancer research and care.
ICYMI – Cancer Leaders Lay Out Policy Road Map for Continued Progress
In case you missed it, a special report, “Accelerating the Delivery of Patient-Centered, High-Quality Cancer Care,” published online yesterday in the American Association for Cancer Research (AACR) journal Clinical Cancer Research. Authored by Turning the Tide Against Cancer co-conveners, the report proposes four key policy recommendations to further the national dialogue on accelerating the delivery of patient-centered, high-quality cancer research and care.
Notably, the report acknowledges that as the oncology community seeks to ensure innovation in cancer research and care continues, it is critical that stakeholders focus their attention on the value cancer research and care provides to patients and society. And the value is evident – in the U.S., cancer death rates are down nearly 22 percent from their peak, and the 5-year survival rate is now 68 percent.
Key recommendations include:
Read more about the progress America’s biopharmaceutical companies have made in cancer research here.
Learn more about PhRMA’s position on payment reforms here.
